COVID-19 Impact on Insomnia Market will Generate Revenue of $5,488 Million, globally, by 2023

The increase in awareness related to long-term effects of insomnia and the severity of the conditions arising due to prolonged insomnia has sought the attention of populace; thereby, leading to increased adoption of insomnia treatments and fueling the market growth.

Global Insomnia Market report it provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consists of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables).

According to a new report published by Allied Market Research, titled, “Insomnia Market by Therapy Type [Non-pharmacological Therapy (Hypnotherapy, Cognitive Behavioral Therapy, Medical Devices, and Other Non-pharmacological Therapy) and Pharmacological Therapy (Prescription Sleep Aids and Over-The-Counter Sleep Aids)] - Global Opportunity Analysis and Industry Forecast, 2017-2023”

Global Insomnia Market was valued at $4,093 million in 2016, and is estimated to reach $5,488 million by 2023, registering a CAGR of 4.2% from 2017 to 2023.

Download PDF Report Sample with statistical info @ https://www.alliedmarketresearch.com/request-sample/2373

Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players operating in the global insomnia market include Merck & Co. Inc., Sanofi, Pfizer, Inc., Takeda Pharmaceutical Company Ltd., Purdue Pharmaceuticals L.P., Eisai, Co. Ltd., Meda Consumer Healthcare Inc., Pernix Therapeutics, Vanda Pharmaceuticals, and ECR Pharmaceuticals.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/2373

Key Benefits
• The study provides an in-depth analysis of the market along with current trends and future estimations to elucidate the imminent investment pockets.
• Extensive analysis of the market is conducted by following key product positioning and monitoring the top competitors within the market framework.
• It offers a quantitative analysis to enable the stakeholders to capitalize on the prevailing market opportunities.
• Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
• Key players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.

Insomnia Market Key Segments:

By Therapy Type
• Non-pharmacological Therapy
o Hypnotherapy
o Cognitive Behavioral Therapy
o Medical Devices
o Other Non-pharmacological Therapy

• Pharmacological Therapy
o Prescription Sleep Aids
o Over-the-counter Sleep Aids

By Geography
• North America
o U.S.
o Canada
o Mexico

• Europe
o Germany
o UK
o France
o Spain
o Rest of Europe

• Asia-Pacific
o Japan
o China
o Australia
o India
o Rest of Asia-Pacific

• LAMEA
o Brazil
o Republic of South Africa
o Saudi Arabia
o Rest of LAMEA

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web:https://www.alliedmarketresearch.com
Follow Us on LinkedIn:https://www.linkedin.com/company/allied-market-research

About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.